NYSE:VSI - Vitamin Shoppe Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$7.55 -0.15 (-1.95 %)
(As of 06/21/2018 04:27 AM ET)
Previous Close$7.55
Today's Range$7.50 - $7.85
52-Week Range$2.95 - $12.00
Volume531,003 shs
Average Volume578,995 shs
Market Capitalization$190.22 million
P/E Ratio19.36
Dividend YieldN/A
Beta0.51
Vitamin Shoppe logoVitamin Shoppe, Inc., through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products. It offers vitamins, minerals, herbs, specialty supplements, sports nutrition products, and other health and wellness products of approximately 900 brands, such as own brands comprising The Vitamin Shoppe, BodyTech, True Athlete, Mytrition, plnt, ProBioCare, Next Step, and Betancourt Nutrition; and national brands, including Optimum Nutrition, Cellucor, Garden of Life, Quest Nutrition, Solaray, Solgar, Megafood, and Nature's Way. The company sells its products through Vitamin Shoppe and Super Supplements retail stores, as well as through its vitaminshoppe.com Website. As of December 30, 2017, it operated through 785 Vitamin Shoppe and Super Supplements retail stores in 45 states, the District of Columbia, and Puerto Rico; and 8 franchise stores in Panama, 5 in Guatemala, 3 in Paraguay, and 2 in Costa Rica. The company was formerly known as VS Holdings, Inc. and changed its name to Vitamin Shoppe, Inc. in November 2009. Vitamin Shoppe, Inc. was founded in 1977 and is headquartered in Secaucus, New Jersey.

Receive VSI News and Ratings via Email

Sign-up to receive the latest news and ratings for VSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Food stores
Sub-IndustrySpecialty Stores
SectorRetail/Wholesale
SymbolNYSE:VSI
CUSIP92849E10
Phone201-868-5959

Debt

Debt-to-Equity Ratio0.47
Current Ratio1.88
Quick Ratio0.44

Price-To-Earnings

Trailing P/E Ratio19.36
Forward P/E Ratio-35.95
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.18 billion
Price / Sales0.16
Cash Flow$13.0172 per share
Price / Cash0.58
Book Value$8.15 per share
Price / Book0.93

Profitability

EPS (Most Recent Fiscal Year)$0.39
Net Income$-252,150,000.00
Net Margins-22.80%
Return on Equity1.28%
Return on Assets0.56%

Miscellaneous

Employees5,573
Outstanding Shares24,230,000

Vitamin Shoppe (NYSE:VSI) Frequently Asked Questions

What is Vitamin Shoppe's stock symbol?

Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."

How were Vitamin Shoppe's earnings last quarter?

Vitamin Shoppe Inc (NYSE:VSI) released its quarterly earnings data on Wednesday, May, 9th. The specialty retailer reported $0.10 earnings per share for the quarter, meeting the consensus estimate of $0.10. The specialty retailer had revenue of $295.96 million for the quarter, compared to analyst estimates of $293.44 million. Vitamin Shoppe had a positive return on equity of 1.28% and a negative net margin of 22.80%. View Vitamin Shoppe's Earnings History.

When is Vitamin Shoppe's next earnings date?

Vitamin Shoppe is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Vitamin Shoppe.

What price target have analysts set for VSI?

5 brokerages have issued 12 month target prices for Vitamin Shoppe's stock. Their forecasts range from $3.00 to $7.00. On average, they expect Vitamin Shoppe's share price to reach $4.95 in the next year. View Analyst Ratings for Vitamin Shoppe.

Who are some of Vitamin Shoppe's key competitors?

Who are Vitamin Shoppe's key executives?

Vitamin Shoppe's management team includes the folowing people:
  • Mr. Colin Frederick Watts, Chief Exec. Officer and Director (Age 52)
  • Ms. Brenda M. Galgano CPA, Chief Financial Officer and Exec. VP (Age 49)
  • Mr. David M. Kastin, Sr. VP, Gen. Counsel & Corp. Sec. (Age 50)
  • Mr. Alexander W. Smith, Exec. Chairman (Age 65)
  • Mr. John Hnanicek, Chief Customer Innovation & Technology Officer and Sr. VP

Has Vitamin Shoppe been receiving favorable news coverage?

Headlines about VSI stock have trended positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Vitamin Shoppe earned a daily sentiment score of 0.25 on Accern's scale. They also assigned media coverage about the specialty retailer an impact score of 47.24 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are Vitamin Shoppe's major shareholders?

Vitamin Shoppe's stock is owned by many different of retail and institutional investors. Top institutional investors include SHAH CAPITAL MANAGEMENT (17.70%), VINTAGE CAPITAL MANAGEMENT LLC (17.70%), VINTAGE CAPITAL MANAGEMENT LLC (14.80%), BlackRock Inc. (12.50%), Dimensional Fund Advisors LP (6.92%) and Tamarack Advisers LP (4.63%). Company insiders that own Vitamin Shoppe stock include Alex Smith, B Michael Becker, Dan Lamadrid, Guillermo Marmol, John D Bowlin, Richard L Markee, Shah Capital Management and Vintage Capital Management Llc. View Institutional Ownership Trends for Vitamin Shoppe.

Which institutional investors are selling Vitamin Shoppe stock?

VSI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Landscape Capital Management L.L.C., OppenheimerFunds Inc., Guggenheim Capital LLC and Prudential Financial Inc.. View Insider Buying and Selling for Vitamin Shoppe.

Which institutional investors are buying Vitamin Shoppe stock?

VSI stock was acquired by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Millennium Management LLC, Schwab Charles Investment Management Inc., Dimensional Fund Advisors LP, GSA Capital Partners LLP and California Public Employees Retirement System. Company insiders that have bought Vitamin Shoppe stock in the last two years include Alex Smith, Guillermo Marmol, John D Bowlin, Shah Capital Management and Vintage Capital Management Llc. View Insider Buying and Selling for Vitamin Shoppe.

How do I buy shares of Vitamin Shoppe?

Shares of VSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vitamin Shoppe's stock price today?

One share of VSI stock can currently be purchased for approximately $7.55.

How big of a company is Vitamin Shoppe?

Vitamin Shoppe has a market capitalization of $190.22 million and generates $1.18 billion in revenue each year. The specialty retailer earns $-252,150,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. Vitamin Shoppe employs 5,573 workers across the globe.

How can I contact Vitamin Shoppe?

Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected]


MarketBeat Community Rating for Vitamin Shoppe (VSI)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  270 (Vote Outperform)
Underperform Votes:  429 (Vote Underperform)
Total Votes:  699
MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe VSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.